Monday, April 4, 2016

"We're not seeing a huge move toward ...

... coinsurance in place of copays. [There's] not a wholesale shift of payers insisting that all drugs move to a percentage of the ... copay. [But we have seen] a shift to pharmacy-specific deductibles."

— Melinda Haren, senior director of access strategies at Zitter Health Insights, discussing with AIS's Specialty Pharmacy News her firm's recently released fifth edition of Managed Care Biologics and Injectables Index.

No comments:

Post a Comment